Literature DB >> 21762258

Clinical value of lead aVR.

Andrés Ricardo Pérez Riera1, Celso Ferreira, Celso Ferreira Filho, Sergio Dubner, Raimundo Barbosa Barros, Francisco Femenía, Adrian Baranchuk.   

Abstract

Lead aVR is the only lead in the surface ECG that does not face the "typically" relevant walls of the left ventricle. Historically, its value has been neglected most likely due to its unusual configuration and direction, which appeared to have little correlation with other more congruous and easily diagnostic frontal leads. The isolation of the unipolar leads in the Standard surface ECG presentation may also have played an important role. Even with this "unfair" neglect, we know nowadays that it is very sensitive to locate obstructed epicardial coronary arteries. Besides helping distinguishing the culprit lesion of an infarct, lead aVR also helps recognizing other conditions that could be of clinical significance such as pericarditis, Brugada syndrome, fascicular blocks of the right branch, ectopic left atrial rhythms, etc. The purpose of this review is to revise the clinical value of lead aVR in the recognition of frequent and not so frequent clinical conditions. ©2011, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21762258      PMCID: PMC6932132          DOI: 10.1111/j.1542-474X.2011.00435.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  26 in total

1.  Recommendation for revision of the standard presentation of the frontal plane ECG leads including reversal of lead aVR (to -aVR): It is time for a change.

Authors:  Robert B Case; Arthur J Moss
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-04       Impact factor: 1.468

Review 2.  Electrocardiographic applications of lead aVR.

Authors:  Kelly Williamson; Amal Mattu; Claire U Plautz; Allan Binder; William J Brady
Journal:  Am J Emerg Med       Date:  2006-11       Impact factor: 2.469

3.  Additional causes of electrocardiographic changes in lead aVR.

Authors:  Yen-Yue Lin; Chin-Wang Hsu; Shi-Jye Chu; Shih-Hung Tsai
Journal:  Am J Emerg Med       Date:  2008-02       Impact factor: 2.469

4.  Electrocardiography pitfalls and artifacts: the 10 commandments.

Authors:  Adrian Baranchuk; Catherine Shaw; Haitham Alanazi; Debra Campbell; Kathy Bally; Damian P Redfearn; Christopher S Simpson; Hoshiar Abdollah
Journal:  Crit Care Nurse       Date:  2009-02       Impact factor: 1.708

5.  Simple electrocardiographic criteria for identifying the site of origin of focal right atrial tachycardia.

Authors:  H Tada; A Nogami; S Naito; M Suguta; M Nakatsugawa; Y Horie; T Tomita; H Hoshizaki; S Oshima; K Taniguchi
Journal:  Pacing Clin Electrophysiol       Date:  1998-11       Impact factor: 1.976

6.  Prediction of acute left main coronary artery obstruction by 12-lead electrocardiography. ST segment elevation in lead aVR with less ST segment elevation in lead V(1).

Authors:  H Yamaji; K Iwasaki; S Kusachi; T Murakami; R Hirami; H Hamamoto; K Hina; T Kita; N Sakakibara; T Tsuji
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

7.  Significance of the initial R wave in lead aVR of the electrocardiogram in the diagnosis of myocardial infarction.

Authors:  N Okamoto; E Simonson; S Ahuja; G Manning
Journal:  Circulation       Date:  1967-01       Impact factor: 29.690

8.  The value of ECG lead aVR in the differential diagnosis of acute inferior wall myocardial infarction.

Authors:  Tong-Wen Sun; Le-Xin Wang; Yan-Zhou Zhang
Journal:  Intern Med       Date:  2007-06-15       Impact factor: 1.271

9.  Significance of exercise-induced ST changes in leads aVR, V5, and V1. Discrimination of patients with single- or multivessel coronary artery disease.

Authors:  Andreas P Michaelides; Zoi D Psomadaki; Maria-Niki K Aigyptiadou; Dimitris J Richter; George K Andrikopoulos; Polychronis E Dilaveris; Konstantinos Tsioufis; Dimitris Tousoulis; Christodoulos Stefanadis; Pavlos K Toutouzas
Journal:  Clin Cardiol       Date:  2003-05       Impact factor: 2.882

Review 10.  Early repolarization variant: epidemiological aspects, mechanism, and differential diagnosis.

Authors:  Andrés Ricardo Pérez Riera; Augusto Hiroshi Uchida; Edgardo Schapachnik; Sérgio Dubner; Li Zhang; Celso Ferreira
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

View more
  5 in total

1.  Impact of T wave amplitude in lead aVR on predicting cardiac events in ischemic and nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator.

Authors:  Yoshihiro Tanaka; Tetsuo Konno; Yudai Tamura; Toyonobu Tsuda; Hiroshi Furusho; Masayuki Takamura; Kenji Sakata; Masakazu Yamagishi; Kenshi Hayashi
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-04-25       Impact factor: 1.468

2.  Complete absence of precordial R waves due to absence of left-sided pericardium.

Authors:  Christian Steinberg; Marie-Josée Pelletier; Jean Champagne
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-08-13       Impact factor: 1.468

3.  Why complicate an important task? An orderly display of the limb leads in the 12-lead electrocardiogram and its implications for recognition of acute coronary syndrome.

Authors:  T Lindow; Y Birnbaum; K Nikus; A Maan; U Ekelund; O Pahlm
Journal:  BMC Cardiovasc Disord       Date:  2019-01-10       Impact factor: 2.298

4.  Prolonged Tpeak -Tend interval is a risk factor for sudden cardiac death in adults with congenital heart disease.

Authors:  Jim T Vehmeijer; Zeliha Koyak; A Suzanne Vink; Werner Budts; Louise Harris; Candice K Silversides; Erwin N Oechslin; Aeilko H Zwinderman; Barbara J M Mulder; Joris R de Groot
Journal:  Congenit Heart Dis       Date:  2019-10-01       Impact factor: 2.007

5.  Clinical utility of aVR lead T-wave in electrocardiogram of patients with ST-elevation myocardial infarction.

Authors:  Babak Kazemi; Seyyed-Reza Sadat-Ebrahimi; Abdolmohammad Ranjbar; Fariborz Akbarzadeh; M Reza Sadaie; Naser Safaei; Mehdi Esmaeil Zadeh-Saboor; Bahram Sohrabi; Samad Ghaffari
Journal:  BMC Cardiovasc Disord       Date:  2021-10-28       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.